(VIANEWS) – First Bank (FRBA), Alkermes plc (ALKS), Main Street Capital Corporation (MAIN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. First Bank (FRBA)
27.8% sales growth and 6.74% return on equity
First Bank provides various banking products and services to individuals, businesses, and governmental entities. The company accepts various deposits, including non-interest bearing demand deposits, interest bearing demand accounts, money market accounts, savings accounts, and certificates of deposit, as well as commercial checking accounts. Its loan products include commercial and industrial loans; commercial real estate loans, such as owner-occupied, investor, construction and development, and multi-family loans; residential real estate loans comprising residential mortgages, first and second lien home equity loans, and revolving lines of credit; and consumer and other loans that include auto, personal, and traditional installment loans. The company also provides electronic banking services, including Internet and mobile banking, electronic bill payment, and banking by phone, as well as ATM and debit cards, and wire and ACH transfer services; remote deposit capture; and cash management services. As of December 31, 2021, it operated 18 full-service branches in Cinnaminson, Cranbury, Delanco, Denville, Ewing, Flemington, Hamilton, Hamilton, Lawrence, Mercerville, Pennington, Randolph, Somerset, and Williamstown counties in New Jersey, as well as Doylestown, Trevose, Warminster, and West Chester counties in Pennsylvania. First Bank was incorporated in 2007 and is headquartered in Hamilton, New Jersey.
Earnings Per Share
As for profitability, First Bank has a trailing twelve months EPS of $1.05.
PE Ratio
First Bank has a trailing twelve months price to earnings ratio of 11.89. Meaning, the purchaser of the share is investing $11.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.74%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Nov 8, 2023, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 1.93%.
2. Alkermes plc (ALKS)
19.7% sales growth and 17.91% return on equity
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA (aripiprazole lauroxil), an extended-release intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL (naltrexone for extended-release injectable suspension) for the treatment of alcohol and opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia; and VUMERITY (diroximel fumarate) for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting and active secondary progressive diseases. The company is also developing LYBALVI (olanzapine/samidorphan), an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and nemvaleukin alfa, an engineered fusion protein to expand tumor-killing immune cells and to avoid the activation of immunosuppressive cells. It has collaboration agreements with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International; a license agreement with Acorda Therapeutics, Inc.; and a license and collaboration agreement with Biogen Swiss Manufacturing GmbH. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, Alkermes plc has a trailing twelve months EPS of $1.24.
PE Ratio
Alkermes plc has a trailing twelve months price to earnings ratio of 19.55. Meaning, the purchaser of the share is investing $19.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.91%.
Sales Growth
Alkermes plc’s sales growth is 71.2% for the current quarter and 19.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 51%, now sitting on 1.59B for the twelve trailing months.
3. Main Street Capital Corporation (MAIN)
10.7% sales growth and 18.19% return on equity
Main Street Capital Corporation is a principal investment firm that primarily provides equity capital to lower middle market companies and debt capital to middle market companies. Main Street's portfolio investments are typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. Main Street seeks to partner with entrepreneurs, business owners and management teams and generally provides "one stop" financing alternatives within its lower middle market portfolio. Main Street's lower middle market companies generally have annual revenues between $10 million and $150 million. Main Street's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies.
Earnings Per Share
As for profitability, Main Street Capital Corporation has a trailing twelve months EPS of $4.97.
PE Ratio
Main Street Capital Corporation has a trailing twelve months price to earnings ratio of 8.21. Meaning, the purchaser of the share is investing $8.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.19%.
Moving Average
Main Street Capital Corporation’s value is higher than its 50-day moving average of $40.01 and above its 200-day moving average of $40.08.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 6, 2023, the estimated forward annual dividend rate is 2.88 and the estimated forward annual dividend yield is 7.06%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Main Street Capital Corporation’s EBITDA is 7.02.
Volume
Today’s last reported volume for Main Street Capital Corporation is 295902 which is 19.06% below its average volume of 365590.
4. U.S. Physical Therapy (USPH)
9.3% sales growth and 7.38% return on equity
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. The company was founded in 1990 and is based in Houston, Texas.
Earnings Per Share
As for profitability, U.S. Physical Therapy has a trailing twelve months EPS of $1.7.
PE Ratio
U.S. Physical Therapy has a trailing twelve months price to earnings ratio of 49.83. Meaning, the purchaser of the share is investing $49.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.38%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
U.S. Physical Therapy’s EBITDA is 2.34.
Volume
Today’s last reported volume for U.S. Physical Therapy is 115723 which is 40.9% above its average volume of 82131.
5. Fomento Economico Mexicano S.A.B. de C.V. (FMX)
8.2% sales growth and 13.28% return on equity
Fomento Económico Mexicano, S.A.B. de C.V., through its subsidiaries, operates as a bottler of Coca-Cola trademark beverages. The company produces, markets, and distributes Coca-Cola trademark beverages in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil, Argentina, and Uruguay. It also operates small-box retail chain stores in Mexico, Colombia, Peru, Chile, and Brazil under the OXXO name; retail service stations for fuels, motor oils, lubricants, and car care products under the OXXO GAS name in Mexico; and drugstores in Chile, Colombia, Ecuador, and Mexico under the Cruz Verde, Fybeca, SanaSana, YZA, La Moderna, and Farmacon names. In addition, the company is involved in the production and distribution of collers, commercial refrigeration equipment, plastic boxes, food processing, and preservation and weighing equipment; and provision of logistic transportation, distribution and maintenance, point-of-sale refrigeration, and plastics solutions, as well as distribution platform for cleaning products and consumables. Further, it operates small-box retail and food convenience chain stores in Switzerland, Germany, Austria, Luxembourg, and the Netherlands under the k kiosk, Brezelkönig, BackWerk, Ditsch, Press & Books, avec, Caffè Spettacolo, and ok.–) names, as well as pretzels under the Ditsch name. The company was founded in 1890 and is based in Monterrey, Mexico.
Earnings Per Share
As for profitability, Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months EPS of $3.95.
PE Ratio
Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months price to earnings ratio of 32.28. Meaning, the purchaser of the share is investing $32.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.28%.
Volume
Today’s last reported volume for Fomento Economico Mexicano S.A.B. de C.V. is 134043 which is 78.36% below its average volume of 619546.
Moving Average
Fomento Economico Mexicano S.A.B. de C.V.’s value is way higher than its 50-day moving average of $108.76 and way above its 200-day moving average of $100.97.
Yearly Top and Bottom Value
Fomento Economico Mexicano S.A.B. de C.V.’s stock is valued at $127.50 at 19:22 EST, above its 52-week high of $119.62.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Fomento Economico Mexicano S.A.B. de C.V.’s EBITDA is 9.32.
6. First Community Bankshares (FCBC)
6.1% sales growth and 10.75% return on equity
First Community Bankshares, Inc. operates as the financial holding company for First Community Bank that provides various banking products and services. It offers demand deposit accounts, savings and money market accounts, certificates of deposit, and individual retirement arrangements; commercial, consumer, and real estate mortgage loans, as well as lines of credit; various credit and debit cards, and automated teller machine card services; and corporate and personal trust services. The company also provides wealth management services, including trust management, estate administration, and investment advisory services; and investment management services. It serves individuals and businesses across various industries, such as education, government, and health services; coal mining and gas extraction; retail trade; construction; manufacturing; tourism; and transportation. As of December 31, 2021, the company operated 49 branches, including 17 branches in West Virginia, 23 branches in Virginia, 7 branches in North Carolina, and 2 branches in Tennessee. First Community Bankshares, Inc. was founded in 1874 and is headquartered in Bluefield, Virginia.
Earnings Per Share
As for profitability, First Community Bankshares has a trailing twelve months EPS of $2.8.
PE Ratio
First Community Bankshares has a trailing twelve months price to earnings ratio of 12.06. Meaning, the purchaser of the share is investing $12.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.75%.
Moving Average
First Community Bankshares’s worth is higher than its 50-day moving average of $31.42 and way higher than its 200-day moving average of $29.57.
